Table 2 Capillaroscopy results in ALS patients and controls.
From: Microvascular abnormalities in skin capillaries of individuals with amyotrophic lateral sclerosis
Control, n = 35 | ALS, n = 28 | p-value | OR [ 95%CI] | |
---|---|---|---|---|
Capillary density, Median [Q1, Q3] | 7.00 [7.00, 8.00] | 7.00 [6.75, 8.00] | 0.761 | |
Capillary diameter, Median [Q1, Q3] | 8.72 [8.00, 10.00] | 10.15 [8.50,12.06] | 0.0111 | |
Dilated capillary, n (%) | 4 (11.43%) | 5 (17.8%) | 0.492 | 1.68 [0.40, 7.48] |
Avascular zones, n | 0 (0.00%) | 0 (0.00%) | > 0.992 | |
Tortuosity, n (%) | < 0.0012 | 1.89 [0.66, 5.54] | ||
Without | 6 (17.14%) | 0 (0.00%) | ||
Mild | 18 (51.43%) | 13 (46.43%) | ||
Moderate | 10 (28.57%) | 5 (17.86%) | ||
Severe | 1 (2.86%) | 10 (35.71%) | ||
Ramified capillaries, n (%) | 4 (11.43%) | 13 (46.43%) | 0.0023 | 6.72 [2.00, 27.19] |
Micro-hemorrhages, n (%) | 0 (0.00%) | 3 (10.71%) | ||
Thrombosis, n | 0 (0.00%) | 0 (0.00%) | > 0.992 | |
Sub-papillary venous plexus, n (%) | 34 (97.14%) | 27 (96.43%) | > 0.992 |